Effect of Ramipril Treatment on Proteinuria and Advanced Glycation End Products in Type 2 Diabetes Mellitus Patients with Nephropathy: One Year Follow up Study
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 17, Issue 12
Abstract
Aims: The present study was carried out to evaluate the effect of angiotensin converting enzyme inhibitor (ACEI) therapy on proteinuria and serum advanced glycation end products (AGEs) level in type 2 diabetes mellitus (T2DM) patients with nephropathy. Study Design: Single-arm prospective longitudinal study. Duration and Place of Study: The study subjects were enrolled from Diabetic and Nephrology clinic at University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India, between September 2013 and July 2014. Methodology: The study subjects comprised of clinically diagnosed T2DM patients (n = 75) with evidence of persistent micro-albuminuria (ACR; 30-299 mg/g creatinine) or overt albuminuria (ACR; ≥300 mg/g creatinine) tested on two separate occasions. These patients were treated with ACE inhibitor; ramipril (5 mg to 20 mg /day) for 12 months. Effectiveness was assessed based on change in urinary albumin/creatinine ratio (ACR) and serum AGEs level. Results: Ramipril treatment produced significant fall in log urinary ACR (P<0.001) and significant reduction in serum AGEs level (P<0.001) during 12 months follow up period as compared to baseline values. Also significant positive correlation between serum AGEs level and urinary ACR was observed at baseline. However, after one year follow up the serum AGEs level and urinary ACR did not correlate significantly. No significant change in serum creatinine and estimated glomerular filtration rate (eGFR) were observed after one year follow up. Conclusions: Apart from antiproteinuric action, ramipril treatment has been found to lower serum AGEs level that may eventually arrest vascular complications in T2DM patients with nephropathy.
Authors and Affiliations
Pawan Kumar Kare, Neerja Aggrawal, Om Prakash Kalra, Basu Dev Banerjee, Parul Varshney, Rishila Ghosh, Neeru Singh, Vinod Kumar Arora, Sri Venkata Madhu, Ashok Kumar Tripathi
Keywords
Related Articles
- EP ID EP341926
- DOI 10.9734/BJMMR/2016/28555
- Views 56
- Downloads 0
Safety and Efficacy of Prolonged Hydroxycarbamide Administration in Patients with Sickle Cell Disease in Northwestern Greece
Hydroxycarbamide (HC) is a ribonucleotide reductase inhibitor which promotes fetal hemoglobin (HbF) induction and has proven efficacy in sickle cell disease (SCD) patients. Given its mechanism of action and prior reports...
Correlative Studies on Anthropometric Indexes for Identifying Obesity in Pregnancy
Currently, Obesity in pregnancy is a major health problem across the globe. In the past 20 years, prevalence of Obesity in pregnancy has doubled, leading to a wide range of complications in pregnancy. To foretell and man...
Lipoprotein-associated Phospholipase A2, Lp-PLA2, and Age, are Predictors for Future Cardiovascular Events in Acute Coronary Syndrome Patients
Aims: We investigated whether Lp-PLA2 activity of blood samples collected 24 h after hospital admission could serve as a predictor of future cardiovascular events in Vietnamese patients with acute coronary syndrome (ACS)...
Clinicopathological Characteristics of Pernicious Anemia: A Study of 300 Patients in Turkey
Aims: Our study was undertaken to examine the laboratory and clinical features of pernicious anemia patients presenting initially at the Turgut Ozal Medical Center, which serves as an important tertiary health center in...
Prevalence and Risk Factors of Metabolic Syndrome among Individuals Living with HIV and Receiving Antiretroviral Treatment in Tanzania
Aim: To estimate the prevalence and risk factors for metabolic syndrome (MetS) among HIV positive patients on antiretroviral therapy (ART) in Tanzania. Study Design: A cross sectional study was conducted among adults ag...